Navigation Links
BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
Date:8/19/2007

in

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio is comprised of two approved products and multiple clinical and preclinical product candidates. Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin, and Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation. Investigational product candidates include Kuvan(TM) (sapropterin dihydrochloride), a Phase 3 product candidate for the treatment of phenylketonuria (PKU), and 6R-BH4 for cardiovascular indications, which is currently in Phase 2 clinical development for the treatment of peripheral arterial disease and sickle cell disease. Both products are being developed in partnership with Merck Serono, a division of Merck KgA of Darmstadt, Germany. For additional information, please visit http://www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

About AnGes MG, Inc.

AnGes MG, Inc., a biopharmaceutical company founded in 1999, was established on an innovative discovery by researchers of Osaka University. The company specializes in research, development and practical application of genetic medicine. Current programs include the Hepatocyte Growth Factor (HGF) genetic medicine which improves blood circulation by regenerating blood vessels, and an NFkB decoy that controls various types of inflammation.

Forward-Looking Statement

This press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc., including, without limitation, statements about: the potential approval of Naglazyme in Japan; the continued clinical development and commercialization of Naglazyme; actions
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
2. GenoLogics Announces Bioinformatics Partnership with Illumina
3. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
4. AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results for Anti-Cancer Compound Perifosine at ASCO Meeting
5. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
6. Inovio Biomedicals Partners to Present New Data from Two Cancer Immunotherapy Clinical Trials
7. Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Companys Investigational Drug to Treat Cocaine and Methamphetamine Addiction
8. Vical Licensee AnGes MG Announces Positive Results of Phase 3 Angiogenesis Trial in Japan
9. KineMed Presents Data Measuring Changes in Reverse Cholesterol Transport for the First Time
10. First Controlled Large-Scale Intervention Angiotensin Receptor Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study Demonstrates Significant Reduction in Blood Pressure and Protection of Organs with Valsartan
11. AEterna Zentaris Reports Positive Results with Cetrorelix in BPH for Japanese Phase 2a Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... MENLO PARK, Calif. , March 2, ... (OTCQX: DMPI) (DelMar and the Company), a company ... in new orphan drug indications, today announced that ... U.S. Patent and Trademark Office (USPTO) for patent ... to improve the therapeutic benefit of suboptimally administered ...
(Date:3/2/2015)... 2, 2015 Edison Investment ... the initiation of full coverage of Abzena  ... Edison,s pharma & biotech analysts Christian Glennie ... Abzena offers a range of key ... and more effective biological products. Antitope (immunogenicity testing, ...
(Date:3/2/2015)... March 2, 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... manufacturer of the t:slim® and t:flex™ Insulin Pumps, today ... offering of common stock have exercised their option to ... at a price to the public of $11.50 per ... is expected to be $64.8 million, after deducting underwriting ...
Breaking Medicine Technology:DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 2DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 3DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 4Edison Initiates Coverage on Abzena 2Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 3
... Mass., July 30 Peptimmune, Inc. a ... of US Patent Number,7,381,790 (the ,790 patent) ... PI-2301 peptide copolymer for the treatment of ... a Phase Ib multiple-ascending dose,double-blind, placebo-controlled randomized ...
... Assay, Only,Automated Transplant Monitoring Test that Meets International Standards for ... ... 30 The ability of blood,tests to precisely measure very ... a significant difference in assuring long-term,viability and survival, according to ...
Cached Medicine Technology:Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis 2Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis 3Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success 2Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success 3
(Date:3/3/2015)... The Data 360 Conference on “Healthcare’s Big ... Dearborn, MI, on March 5, 2015. Norman T. Kutemperor, ... He is known internationally as “The Father of NoSQL” and ... earned due to years of R&D on NoSQL DBs, culminating ... 10 years ago. Subsequent developments in Big Data-related technologies (such ...
(Date:3/3/2015)... The authors Tracey Webb and Richard Mowbray have always ... a good and healthy diet . In “ Crude ... created an ingenious book that shows readers how to prepare ... , “Crude Food” shows readers that, in modern society, people ... over processed refined foods , such as wheat, sugars ...
(Date:3/3/2015)... Dr. Stephen Edgerton, a ... has achieved Accredited Member Status in the American ... this accomplishment after completing a rigorous credentialing process ... the submission of clinical cases for examination. ... up in Connecticut, Charlotte, North Carolina, Caracas, Venezuela ...
(Date:3/3/2015)... 03, 2015 Aureus Medical Group (web: ... jobs, has announced that it will participate as an ... Tuesday, March 17, 2015 in St. Louis, MO. , ... meet job-seeking residents and fellows in a comfortable, relaxed ... will be available to speak with attendees about ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Formetco today ... billboard design. The FTX uses state-of-the-art technology to ... performance reliability, and owner satisfaction. An item of ... the exclusive Formetco 10 year LED Brightness Warranty. , ... to be a superior billboard among any other billboard ...
Breaking Medicine News(10 mins):Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 2Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 4Health News:New book ‘Crude Food’ gives readers ingenious ways to create healthy meals 2Health News:New book ‘Crude Food’ gives readers ingenious ways to create healthy meals 3Health News:Dr. Edgerton, a Dentist in Wilmington, NC, Achieves Accredited Status in AACD 2Health News:Formetco Launches Innovative LED Billboard System 2
... Arlington-based Equal Health,once again contributed generously to Santa,s Helpers, ... affiliate WFAA founded the annual event to help out,during ... economically,disadvantaged families. , On Wednesday, ... company,s donations to the television studio. "We,ve been,donating the ...
... National Cervical Health Awareness Month, Acting Secretary of Health Everette ... prevention and the need for pap tests. "Every January ... all Pennsylvanians to do what they can to improve their ... Cervical Cancer Month, I want to remind our mothers, sisters, ...
... at huge costs here in the United States , , ... costing the small Canadian province of Quebec, population 7 ... , No doubt, sleepless nights from Seattle to Tampa ... more. , Susan Zafarlotfi, clinical director of the Institute ...
... and flu at bay , , FRIDAY, Jan. 2 (HealthDay News) -- ... that doctors stand by as the best way to keep yourself ... is one of the simplest and most effective ways to keep ... experts say. , "Disease transmission is hand-to-hand combat, at least for ...
... Lewy bodies, clumps of aggregated proteins inside cells, ... disease and other neurodegenerative diseases. , The presence ... recycling and waste disposal, leading to the puzzle: ... , One possible answer: by breaking a survival ...
... the stereotypes of medical education from the student perspective: ... a novel Brandeis study published in Academic Medicine ... dominant environment of academic medicine from the perspective of ... , The study raises questions about how the ...
Cached Medicine News:Health News:Santa Gets a Little Help from Equal Health 2Health News:Department of Health Recognizes January As Cervical Health Awareness Month 2Health News:Insomnia Costs Billions in Lost Productivity 2Health News:Insomnia Costs Billions in Lost Productivity 3Health News:To Protect Yourself, Wash Those Germs Away 2Health News:To Protect Yourself, Wash Those Germs Away 3Health News:To Protect Yourself, Wash Those Germs Away 4Health News:Toxicity mechanism identified for Parkinson's disease 2Health News:The culture of medicine 2
... natural anatomy of the eyelid for ... inserter/dilator instrument for ease of insertion. ... plugs feature the unique slanted collarette ... the eyelid. The slightly larger bulb ...
Ellipsoid tip probe with sufficient rigidity to go through stenosis, yet round, pointed & flexible enough to avoid creating false passage....
For canalicular laceration involving external 2/3 of one canaliculus. Medical grade silicone. Box of 3, sterile. Note: For safe and proper insertion of the punctum plug above, we recommend the use of...
For Canalicular Stenosis. Non-traumatic tip. Silicone tubing swaged into probe. Note: Tubing securely swaged into malleable stainless steel probes. Medical grade silicone. Box of 3, sterile....
Medicine Products: